Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Bot

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|February 13, 2024
Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapyStephanie N Shishido, Olivia Hart, Sujin Jeong, et al.
European Journal of Immunology|January 5, 2002
Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safetyTom Wolfe, Adrian Bot, Anna Hughes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2004
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristicsLuis Dellamary, Dan J Smith, Amy Bloom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanomaJeffrey Weber, William Boswell, John Smith, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2019
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinomaIzak Faiena, Stephanie H Astrow, David A Elashoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 22, 2024
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial CarcinomasIzak Faiena, Sabina Adhikary, Colleen Schweitzer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 16, 2011
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumorsJeffrey S Weber, Nicholas J Vogelzang, Marc S Ernstoff, et al.
Vaccine|May 12, 2009
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptidesKent A Smith, Victor L Tam, Raymond M Wong, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|February 13, 2024
Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapyStephanie N Shishido, Olivia Hart, Sujin Jeong, et al.
European Journal of Immunology|January 5, 2002
Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safetyTom Wolfe, Adrian Bot, Anna Hughes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2004
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristicsLuis Dellamary, Dan J Smith, Amy Bloom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanomaJeffrey Weber, William Boswell, John Smith, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2019
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinomaIzak Faiena, Stephanie H Astrow, David A Elashoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 22, 2024
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial CarcinomasIzak Faiena, Sabina Adhikary, Colleen Schweitzer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 16, 2011
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumorsJeffrey S Weber, Nicholas J Vogelzang, Marc S Ernstoff, et al.
Vaccine|May 12, 2009
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptidesKent A Smith, Victor L Tam, Raymond M Wong, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Pageof 12